Common use of Progression to Co-Development Phase Clause in Contracts

Progression to Co-Development Phase. Within […***…] of the date of POC Phase Completion, Adaptimmune shall provide to Bellicum […***…]. The Adaptimmune […***…] will be reviewed by the JDC and JSC, and the Parties will discuss in good faith and will mutually agree whether or not to proceed to the Co-Development Phase; provided that neither Party is required to proceed to the Co-Development Phase under discussion. The date of such mutual agreement of the Parties to proceed to the Co-Development Phase, as evidenced by minutes of the applicable JSC meeting, shall constitute “Co-Development Start”. Where the JSC does not and/or the Parties do not agree to proceed to the Co-Development Phase within […***…] of provision of such Adaptimmune […***…] and the POC Phase results by Adaptimmune, then this Agreement shall automatically terminate in accordance with Clause 17.5 (and in this event, Clause 17.7 shall apply).

Appears in 1 contract

Sources: Co Development and Co Commercialisation Agreement (Bellicum Pharmaceuticals, Inc)

Progression to Co-Development Phase. Within […***…] * of the date of POC Phase Completion, Adaptimmune shall provide to Bellicum […***…]* . The Adaptimmune […***…] * will be reviewed by the JDC and JSC, and the Parties will discuss in good faith and will mutually agree whether or not to proceed to the Co-Development Phase; provided that neither Party is required to proceed to the Co-Development Phase under discussion. The date of such mutual agreement of the Parties to proceed to the Co-Development Phase, as evidenced by minutes of the applicable JSC meeting, shall constitute “Co-Development Start”. Where the JSC does not and/or the Parties do not agree to proceed to the Co-Development Phase within […***…] * of provision of such Adaptimmune […***…] * and the POC Phase results by Adaptimmune, then this Agreement shall automatically terminate in accordance with Clause 17.5 (and in this event, Clause 17.7 shall apply).

Appears in 1 contract

Sources: Co Development and Co Commercialisation Agreement (Adaptimmune Therapeutics PLC)